All PlansAdministrativeLow impact
Voluntary nationwide recall: Cyclobenzaprine (Unichem – August 2025)
UPMC Health Plan·Family Medicine, Internal Medicine, General Practice +3 more·Pharmacy
We identified it
Jun 20, 2026
Summary
Unichem Pharmaceuticals has issued a voluntary recall of Cyclobenzaprine 10mg tablets (lot GMML24026A) due to mislabeling - bottles actually contain Meloxicam 7.5mg tablets instead. This is a medication safety recall that does not directly impact billing procedures but may affect patient care for those who received the recalled lot.
Action Required
Immediately: Clinical staff should identify patients who may have received Cyclobenzaprine from lot GMML24026A and contact them to stop using the product and return it to the pharmacy. Providers should assess patients for any adverse effects from unknowingly taking Meloxicam and document any related encounters appropriately.